U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Cytarabine Injection
Status: Currently in Shortage
»Date first posted: 09/24/2021
»Therapeutic Categories: Oncology; Pediatric

Expand all

Fresenius Kabi USA, LLC (Revised 04/16/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 100 mg/1 mL (NDC 63323-120-20) Unavailable Check wholesaler for inventory; Backordered. Next release May 2024.

Hospira, Inc., a Pfizer Company (Revised 03/28/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cytarabine, Injection, 20 mg/1 mL (NDC 61703-305-38) Available Delay in shipping of the drug
Cytarabine, Injection, 100 mg/1 mL (NDC 61703-319-22) Available
Cytarabine, Injection, 20 mg/1 mL (NDC 61703-304-36) Available
Cytarabine, Injection, 20 mg/1 mL (NDC 61703-303-46) Available

Meitheal Pharmaceuticals, Inc. (Reverified 03/20/2024)

Company Contact Information:
844-824-8426

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 2 g/20 mL (NDC 71288-109-20) Available
Back to Top